Standout Papers

Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 ... 2022 2026 2023 2024125
  1. Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial (2022)
    Hugh Montgomery, Richard Hobbs et al. The Lancet Respiratory Medicine

Immediate Impact

64 standout
Sub-graph 1 of 23

Citing Papers

The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation
2024 Standout
Persistent SARS-CoV-2 infection: significance and implications
2024 Standout
2 intermediate papers

Works of Douglas Arbetter being referenced

Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
2022 Standout

Author Peers

Author Last Decade Papers Cites
Douglas Arbetter 177 132 29 128 12 351
Francesco Del Sole 163 119 13 90 13 402
Margarita Kushnir 149 173 4 86 18 302
Eunyoung Suh 243 279 3 91 8 388
Enric Grau 106 142 7 48 12 327
Hooman Poor 89 84 22 141 16 375
Rui Guerreiro 83 28 15 78 19 313
Jorge del-Toro-Cervera 45 222 8 225 17 377
Hilary Evans 95 66 9 25 12 341
Lucía Ordieres‐Ortega 37 230 11 251 18 367
Gianluigi Biava 47 49 4 210 8 337

All Works

Loading papers...

Rankless by CCL
2026